Rami Aviram - Endymed Vice President - Finance

All Insiders . Israel . 
Stock . Endymed . Stakeholders . Insider . Rami Aviram
ENDY Stock   295.00  1.00  0.34%   

President

Mr. Rami Aviram was appointed Vice President Finance at Endymed Ltd effective July 22, 2018. His work experience includes the following roles Chief Financial Officer at Syneron Medical Ltd and Finance Director at Syneron Medical Ltd . He holds a BS degree in Computer Science and Economics from Haifa University, a Bachelors degree in Accounting from Bar Ilan University and a Masters degree in Economics from Haifa University. since 2018.
Age 44
Tenure 6 years
Phone855 363 9633
Webhttps://www.endymed.com

Endymed Management Efficiency

The company has return on total asset (ROA) of 0.0385 % which means that it generated a profit of $0.0385 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2146 %, meaning that it generated $0.2146 on every $100 dollars invested by stockholders. Endymed's management efficiency ratios could be used to measure how well Endymed manages its routine affairs as well as how well it operates its assets and liabilities.
Endymed has accumulated 463 K in total debt with debt to equity ratio (D/E) of 7.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Endymed has a current ratio of 2.53, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Endymed until it has trouble settling it off, either with new capital or with free cash flow. So, Endymed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endymed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endymed to invest in growth at high rates of return. When we think about Endymed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Yuval RamonElbit Systems
57
Marco RacanelliTower Semiconductor
56
Akhtar AshfaqOpko Health
N/A
Avi MizrachiElbit Systems
60
Gary SaundersTower Semiconductor
54
David StarkTeva Pharmaceutical Industries
54
Kevin MannixTeva Pharmaceutical Industries
N/A
Richard DaniellTeva Pharmaceutical Industries
52
Sven DethlefsTeva Pharmaceutical Industries
54
Zmira ShternfeldLavieTower Semiconductor
52
Avi StrumTower Semiconductor
61
Ilan RabinovichTower Semiconductor
61
Nati SomekhTower Semiconductor
48
Brendan OGradyTeva Pharmaceutical Industries
52
Yoram ShmuelyElbit Systems
62
Oren ShiraziTower Semiconductor
53
Mark SabagTeva Pharmaceutical Industries
52
Zeev GoferElbit Systems
66
Ilan PacholderElbit Systems
64
Eliyahu KalifTeva Pharmaceutical Industries
50
Yossi NetzerTower Semiconductor
59
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. Endymed (ENDY) is traded on Tel Aviv Stock Exchange in Israel and employs 41 people.

Management Performance

Return On Equity0.21
Return On Asset0.0385

Endymed Leadership Team

Elected by the shareholders, the Endymed's board of directors comprises two types of representatives: Endymed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endymed. The board's role is to monitor Endymed's management team and ensure that shareholders' interests are well served. Endymed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endymed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph Levtzler, Clinical VP
Rami Aviram, Vice President - Finance
Yossi CPA, Chief Officer
Sima Weissman, VP RD
Bill Scott, Pres Inc
Amir Ganun, VP Marketing

Endymed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endymed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.21
Return On Asset0.0385
Profit Margin0.14 %
Operating Margin0.06 %
Current Valuation1.85 M
Shares Outstanding13.76 M
Shares Owned By Insiders58.11 %
Price To Book0.70 X
Price To Sales1.52 X
Revenue21.78 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Endymed Stock

Endymed financial ratios help investors to determine whether Endymed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endymed with respect to the benefits of owning Endymed security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY